Docking assisted design of novel 4-adamantanyl-2-thiazolylimino-5-arylidene-4-thiazolidinones as potent NSAIDsFootnote^$

^$Presented at the 9th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources, CMTPI-2017, 27–30 October 2017, Goa, India.

References

• J.C. Lombardino, Nonsteroidal Antiinflammatory Drugs, Wiley-Interscience, John Wiley & Sons, New York, NY, 1983.
   Google Scholar
• C.J. Smith, Y. Zhang, C.M. Koboldt, J. Muhammad, B.S. Zweifel, A. Shaffer, J.J. Talley, J.L. Masferre, K. Seibert, and P.C. Iskson, Pharmacological analysis of cycloxygenase-1 in inflammation, Proc. Natl Acad. Sci. USA 95 (1998), pp. 1313–1318.
   PubMed Web of Science ®Google Scholar
• C.J. Hawkey, COX-2 inhibitors, Lancet 353 (1999), pp. 307–331.
   PubMed Web of Science ®Google Scholar
• J.Y. Jouzeau, B. Terlain, A. Abid, E. Nedelec, and P. Netter, Cyclooxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs, Drugs 53 (1997), pp. 563–582.
   PubMed Web of Science ®Google Scholar
• J.Y. Fu, J.L. Masferrer, K. Seibert, A. Raz, and P. Needleman, The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes, J. Biol. Chem. 265 (1990), pp. 16737–16740.
   PubMed Web of Science ®Google Scholar
• S.G. Wendell, C. Baffi, and F. Holguin, Fatty acids, inflammation, and asthma, J. Clin. Immunol. 133 (2014), pp. 1255–1264.
   Web of Science ®Google Scholar
• M.G. Belvisi, M. Saunders, M. Yacoub, and J.A. Mitchell, Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth, Br. J. Pharmacol. 125 (1998), pp. 1102–1108.
   PubMed Web of Science ®Google Scholar
• J. Martel-Pelletier, D. Lajeunesse, P. Reboul, and J.-P. Pelletier, Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs, Ann. Rheum. Dis. 62 (2003), pp. 501–509.
   PubMed Web of Science ®Google Scholar
• A. Sala, G.M. Aliev, G. Rossoni, F. Berti, C. Buccellati, G. Burnstock, G. Folco, and J. Maclouf, Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit, Blood 87 (1996), pp. 1824–1832.
   PubMed Web of Science ®Google Scholar
• B.M. Peskar, Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach, Gastroenterology 100 (1991), pp. 619–626.
   PubMed Web of Science ®Google Scholar
• Y.B. Park, C.W. Ahn, H.K. Choi, S.H. Lee, B.H. In, H.C. Lee, C.M. Nam, and S.K. Lee, Atherosclerosis in rheumatoid arthritis: Morphologic evidence obtained by carotid ultrasound, Arthritis Rheum. 46 (2002), pp. 1714–1719.
   PubMedGoogle Scholar
• X. de Leval, F. Julemont, J. Delarge, B. Pirotte, and J.-M. Dogne, New trends in dual 5-LOX/COX inhibition, Curr. Med. Chem. 9 (2002), pp. 941–962.
   PubMed Web of Science ®Google Scholar
• M. Bayes, X. Rabasseda, and J.R. Prous, Gateways to clinical trials, Methods Find. Exp. Clin. Pharmacol. 24 (2002), pp. 525–551.
   PubMedGoogle Scholar
• P.N. Rao, Q.H. Chen, and E.E. Knaus, Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: Dual inhibitors of cyclooxygenases and lipoxygenases, J. Med. Chem. 49 (2006), pp. 1668–1683.
   PubMed Web of Science ®Google Scholar
• G.N. Ziakas, E.A. Rekka, A.M. Gavalas, P.T. Eleftheriou, and P.N. Kourounakis, New analogues of butylated hydroxytoluene as anti-inflammatory and antioxidant agents, Bioorg. Med. Chem. 14 (2006), pp. 5616–5624.
   PubMed Web of Science ®Google Scholar
• G.N. Ziakas, E.A. Rekka, A.M. Gavalas, P.T. Eleftheriou, K.S. Tsiakitzis, and P.N. Kourounakis, Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile, Bioorg. Med. Chem. 13 (2005), pp. 6485–6492.
   PubMed Web of Science ®Google Scholar
• C. Kharbanda, M.S. Alam, H. Hamid, K. Javed, S. Bano, A. Dhulap, Y.S. Ali, S. Nazreen, and S. Haider, Synthesis and evaluation of pyrazolines bearing benzothiazole as anti-inflammatory agents, Bioorg. Med. Chem. 21 (2014), pp. 5804–5812.
   Google Scholar
• P. Patel, J. Pillai, N. Darji, and B. Patel, Recent advance in anti inflammatory activity of benzothiazole derivatives, Int. J. Drug Res. Tech. 22 (2012), pp. 170–176.
   Google Scholar
• V. Kumar, S. Sharma, and A. Husain, A. Synthesis and in vivo anti-inflammatory and analgesic activities of oxadiazoles clubbed with benzothiazole nucleus, ICPJ 4 (2015), pp. 457–461.
   Google Scholar
• A.F.S. Rostom, I.M. El-Ashmawy, H.A. Abd El Razik, M.H. Badr, and H.M.A. Ashour, Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents, Bioorg. Med. Chem. 17 (2009), pp. 882–895.
   PubMed Web of Science ®Google Scholar
• A.D. Taranalli, A.R. Bhat, S. Srinivas, and E. Saravanan, Antiinflammatory, analgesic and antipyretic activity of certain thiazolidinones, Indian J. Pharm. Sci. 70 (2008), pp. 159–164.
   PubMed Web of Science ®Google Scholar
• A.H. Abdelazeem, M.T. El-Saadi, A.G. Safi El-Din, and S.M. El-Moghazy, Design, synthesis and biological evaluation of novel diphenylthiazole-thiazolidin-4-one-based derivatives as anti-inflammatory/analgesic agents, J. Chem. Pharm. Res. 7 (2015), pp. 1073–1079.
   Google Scholar
• A. Geronikaki, D. Hadjipavlou-Litina, A. Zablotskaya, and I. Segal, Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents, Bioinorg. Chem. Appl. (2007), Article ID 92145, 7 pages, http://doi.org/10.1155/2007/92145.
   Web of Science ®Google Scholar
• A.A. Lagunin, A. Geronikaki, P.T. Eleftheriou, D.I. Hadjipavlou-Litina, D.A. Filimonov, and V.V. Poroikov, Computer-aided discovery of potential anti-inflammatory thiazolidinones with dual 5-LOX/COX inhibition, J. Med. Chem. 51 (2008), pp. 1601–1609.
   PubMed Web of Science ®Google Scholar
• O. Kouatly, A. Geronikaki, Ch Kamoutsis, D. Hadjipavlou-Litina, and Ph Eleftheriou, Adamantane derivatives of thiazolyl N-substituted amide, as possible non-steroidal antiinflammatory agents, Eur. J. Med. Chem. 44 (2009), pp. 1198–1204.
   PubMed Web of Science ®Google Scholar
• A.A. Kadi, N.R. El-Brollosy, O.A. Al-Deeb, E.E. Habib, T.M. Ibrahim, and A.A. El-Emam, Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles, Eur. J. Med. Chem. 42 (2007), pp. 235–242.
   PubMed Web of Science ®Google Scholar
• M.A. Al-Omar, E.S. Al-Abdullah, I.A. Shehata, E.E. Habib, T.M. Ibrahim, and A.A. El-Emam, Synthesis, antimicrobial, and anti-inflammatory activities of novel 5-(1-adamantyl)-4 arylideneamino-3-mercapto-1,2,4-triazoles and related derivatives, Molecules 15 (2010), pp. 2526–2550.
   PubMed Web of Science ®Google Scholar
• A.A. Kadi, E.S. Al-Abdullah, I.A. Shehata, E.E. Habib, T.M. Ibrahim, and A.A. El-Emam, Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives, Eur. J. Med. Chem. 45 (2010), pp. 5006–5011.
   PubMed Web of Science ®Google Scholar
• A.A. El-Emam, O.A. Al-Deeb, M. Al-Omar, and J. Lehmann, Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones, Bioorg. Med. Chem. 12 (2004), pp. 5107–5113.
   PubMed Web of Science ®Google Scholar
• U. Calis, M. Yarim, M. Koksal, and M. Ozalp, Synthesis and antimicrobial activity evaluation of some new adamantane derivatives, Arzneimittelforschung 52 (2002), pp. 2778–2781.
   Web of Science ®Google Scholar
• J. Sun, S. Wang, W. Bu, M.-Y. Wei, W.-W. Li, M.-Na Yao, Z.-Y. Ma, C.-T. Lu, H.-H. Li, N.-P. Hu, E.-H. Zhang, G.-D. Yang, A.-D. Wen, and X.-H. Zhu, Synthesis of a novel adamantyl nitroxide derivative with potent anti-hepatoma activity in vitro and in vivo, Am. J Cancer Res. 6 (2016), pp. 1271–1286.
   PubMed Web of Science ®Google Scholar
• I. Papanastasiou, A. Tsotinis, N. Kolocouris, S.P. Nikas, and A. Vamvakides, New aminoadamantane derivatives with antiproliferative activity, Med. Chem. Res. 23 (2014), pp. 1966–1975.
   Google Scholar
• N. Tsuzuki, T. Hama, M. Kawada, A. Hasui, R. Konishi, S. Shiwa, Y. Ochi, S. Futaki, and K. Kitagawa, Adamantane as a brain-directed drug carrier for poorly absorbed drug 2. AZT Derivatives conjugated with the 1-adamantane moiety, J. Pharm. Sci. 83 (1994), pp. 481–484.
   PubMed Web of Science ®Google Scholar
• E.A. Val’dman, T.A. Voronina, and L.N. Nerobkova, The antiparkinson activity of a new adamantane derivative, Eksp. Klin. Farmakol. 62 (1999), pp. 3–6.
   PubMedGoogle Scholar
• P. Vicini, F. Zani, P. Cozzini, and I. Doytchinova, Hydrazones of 1,2-benzisothiazole hydrazides: Synthesis, antimicrobial activity and QSAR investigations, Eur. J. Med. Chem. 37 (2002), pp. 553–564.
   PubMed Web of Science ®Google Scholar
• F. Zani, P. Vicini, and M. Incerti, Synthesis and antimicrobial properties of 2-(benzylidene-amino)-benzo[d]isothiazol-3-ones, Eur. J. Med. Chem. 39 (2004), pp. 135–140.
   PubMed Web of Science ®Google Scholar
• G. Bruno, L. Costantino, C. Curinga, R. Maccari, F. Monforte, F. Nicolo, R. Ottana, and M.G. Vigorita, Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones, Bioorg. Med. Chem. 10 (2002), pp. 1077–1084.
   PubMed Web of Science ®Google Scholar
• A. Geronikaki, and G. Theophilidis, Synthesis of 2-(aminοαcetylamino)thiazole derivatives and comparison of their local anaesthetic activity by method of action potential, Eur. J. Med. Chem. 27 (1992), pp. 709–716.
   Web of Science ®Google Scholar
• P. Saura, J.-D. Maréchal, L. Masgrau, J.M. Lluchab, and A. Gonzalez-Lafont, Computational insight into the catalytic implication of head/tail-first orientation of arachidonic acid in human 5-lipoxygenase: Consequences for the positional specificity of oxygenation, Phys. Chem. Chem. Phys. 18 (2016), pp. 23017–23035.
   PubMed Web of Science ®Google Scholar
• R. Huey, G.M. Morris, A.J. Olson, and D.S. Goodsell, A semiempirical free energy force field with charge-based desolvation, J. Comp. Chem. 28 (2007), pp. 1145–1152.
   PubMed Web of Science ®Google Scholar
• E. Pontiki, D. Hadjipavlou-Litina, K. Litinas, O. Nicolotti, and A. Carotti, Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities, Eur. J. Med. Chem. 46 (2011), pp. 191–200.
   PubMed Web of Science ®Google Scholar
• D. Lapenna, G. Ciofani, S.D. Pierdomenico, M. Neri, C. Cuccurullo, M.A. Giamberardino, and F. Cuccurullo, Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation, Biochim. Biophys. Acta. 1790 (2009), pp. 25–30.
   PubMed Web of Science ®Google Scholar
• I.B. Taraporewala, and J.M. Kauffman, Synthesis and structure-activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridinealkanoic acids and 4-(2-carboxyphenyl)aminobenzenealkanoic acids, J. Pharm. Sci. 79 (1990), pp. 173–178.
   PubMed Web of Science ®Google Scholar
• R.K. Somvanshi, A.K. Singh, M. Saxena, B. Mishra, and S. Dey, Development of novel peptide inhibitor of lipoxygenase based on biochemical and BIAcore evidences, Biochim. Biophys. Acta. 1784 (2008), pp. 1812–1817.
   PubMedGoogle Scholar
• A.R. Brash, Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate, J. Biol. Chem. 274 (1999), pp. 23679–23682.
   PubMed Web of Science ®Google Scholar
• D. Shibata, and B. Axelrod, Plant lipoxygenases, J. Lipid Mediat. Cell Signal. 12 (1995), pp. 213–228.
   PubMedGoogle Scholar
• P. Aparoy, R.N. Reddy, L. Guruprasad, M.R. Reddy, and P. Reddanna, Homology modeling of 5-lipoxygenase and hints for better inhibitor design, J. Comput. Aided Mol. Des. 22 (2008), pp. 611–619.
   PubMed Web of Science ®Google Scholar
• P.N. Rao, Q.H. Chen, and E.E. Knaus, Synthesis and structure–activity relationship studies of 1,3-diarylprop-2-yn-1-ones: Dual inhibitors of cyclooxygenases and lipoxygenases, J. Med. Chem. 49 (2006), pp. 1668–1683.
   PubMed Web of Science ®Google Scholar